Get the Stockscreener App
2.37
9.89%
-0.26
After Hours:
2.40
0.03
+1.27%
Enveric Biosciences Inc stock is traded at $2.37, with a volume of 81,895.
It is down -9.89% in the last 24 hours and down -41.34% over the past month.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
See More
Previous Close:
$2.63
Open:
$2.58
24h Volume:
81,895
Relative Volume:
0.13
Market Cap:
$3.30M
Revenue:
-
Net Income/Loss:
$-15.08M
P/E Ratio:
-0.3692
EPS:
-6.42
Net Cash Flow:
$-11.56M
1W Performance:
-18.56%
1M Performance:
-41.34%
6M Performance:
-82.83%
1Y Performance:
-88.24%
1-Day Range:
$2.14
$2.59
1-Week Range:
$2.14
$3.11
52-Week Range:
$2.14
$54.00
Enveric Biosciences Inc Stock (ENVB) Company Profile
Name
Enveric Biosciences Inc
Sector
Industry
Phone
239-302-1707
Address
245 FIRST STREET RIVERVIEW II 18TH FLOOR, CAMBRIDGE
Compare ENVB vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENVB
Enveric Biosciences Inc
|
2.37 | 3.66M | 0 | -15.08M | -11.56M | -6.42 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.92 | 116.41B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
785.51 | 81.05B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
811.45 | 50.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.16 | 43.76B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
353.92 | 38.40B | 4.98B | 69.60M | 525.67M | 0.5198 |
Enveric Biosciences Inc Stock (ENVB) Latest News
Enveric Biosciences registers $1.35 million in new shares under ATM agreement - Investing.com
Enveric Biosciences Expands At-The-Market Equity Offering Capacity - TipRanks
Enveric Biosciences Registers Additional Shares for ATM Offering - TradingView
Enveric Biosciences (NASDAQ:ENVB) Trading Down 7.4% – Should You Sell? - Defense World
Enveric Biosciences Inc. (ENVB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Enveric licenses RCANN trademark portfolio to TOTEC Pharma By Investing.com - Investing.com South Africa
Enveric Biosciences (ENVB) Licenses Trademark Portfolio to Totec Pharma - GuruFocus
Enveric Biosciences closes $1.5 million registered direct offering By Investing.com - Investing.com Australia
Is Enveric Biosciences Inc. being accumulated by smart money2025 Earnings Impact & Daily Technical Stock Forecast Reports - mfd.ru
Enveric licenses RCANN trademark portfolio to TOTEC Pharma - Investing.com
Enveric Biosciences Expands Collaboration with TOTEC Pharma through Trademark License and Option - Business Wire
Enveric Biosciences Announces Closing Of $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - TradingView
Enveric Biosciences Raises Capital Through Equity Offering - TipRanks
Enveric Biosciences closes $1.5 million registered direct offering - Investing.com
Enveric Biosciences Signs Securities Purchase Agreement With Institutional Investors - TradingView
Enveric Biosciences Announces Closing of $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - Business Wire
Enveric to sell 328,802 shares at $4.41 in registered direct offering - TipRanks
Enveric Biosciences raises $1.5 million in registered direct offering By Investing.com - Investing.com Canada
Enveric Biosciences (ENVB) Announces Stock and Warrant Offering - GuruFocus
Enveric Biosciences Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - Chartmill
US Stocks Recap: Does Enveric Biosciences Inc have high return on assets2025 Support & Resistance & Detailed Earnings Play Strategies - baoquankhu1.vn
Dow Update: Will RPID benefit from rising consumer demand2025 Earnings Impact & Weekly Stock Breakout Alerts - baoquankhu1.vn
Bond Watch: What are the risks of holding Central Plains Bancshares IncPortfolio Value Summary & Short-Term Trading Alerts - baoquankhu1.vn
Technical Analysis: Should I invest in Enveric Biosciences Inc before earningsWeekly Risk Summary & Fast Entry and Exit Trade Plans - baoquankhu1.vn
Rally Mode: Is Enveric Biosciences Inc currently under institutional pressure2025 Price Momentum & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn
Published on: 2026-01-15 09:34:41 - baoquankhu1.vn
Geopolitics Watch: Can Enveric Biosciences Inc stock hit analyst price targetsJuly 2025 Action & Fast Entry High Yield Tips - Bộ Nội Vụ
Enveric Biosciences secures $3.1M through warrant exercise - MSN
Enveric Biosciences, Inc.Common Stock (NQ: ENVB - FinancialContent
Is Enveric Biosciences Inc. stock overvalued by current metricsDurability and Wear Notes & updated model highlights and notes - ulpravda.ru
Can Enveric Biosciences Inc. (SLZ) stock double in coming yearsJuly 2025 Review & Community Trade Idea Sharing Platform - ulpravda.ru
Why Enveric Biosciences Inc. stock remains resilient2025 Winners & Losers & Technical Pattern Alert System - Улправда
Will Enveric Biosciences Inc. (SLZ) stock benefit from commodity supercycleJuly 2025 Spike Watch & Breakout Confirmation Trade Signals - Улправда
Is Enveric Biosciences Inc. (SLZ) stock supported by free cash flowPortfolio Profit Report & AI Driven Stock Movement Reports - ulpravda.ru
How institutional buying supports Enveric Biosciences Inc. stockQuarterly Performance Summary & Consistent Return Strategy Ideas - ulpravda.ru
Enveric Biosciences trading halted, volatility trading pause - MSN
2026 world cup team news insights: Is Enveric Biosciences Inc. stock affected by interest rate hikes2026 world cup usa national team qualification key players high defensive line odds analysis guide - ulpravda.ru
Is Enveric Biosciences Inc. stock affected by interest rate hikes2026 world cup usa national team qualification defensive leaders set piece tactics match prediction expert opinion - Улправда
Dow Theory LettersEnveric Biosciences, Inc.Common Stock (Nasdaq:ENVB) Stock Quote - FinancialContent
Trading Recap: Is Enveric Biosciences Inc SLZ stock undervalued historicallyJuly 2025 Pullbacks & High Conviction Investment Ideas - moha.gov.vn
Enveric Biosciences Inc. (NASDAQ: ENVB)Share Price and Research - intelligentinvestor.com.au
Insider Sell: Will Enveric Biosciences Inc SLZ stock see insider accumulation2025 Earnings Impact & Long-Term Investment Growth Plans - moha.gov.vn
Enveric Biosciences Inc SLZ Stock Analysis and ForecastReal Estate Investment Trusts & Outstanding Growth Opportunities - earlytimes.in
Why did ENVB stock more than double in value today? - MSN
Why Is ENVB Stock Rising Today? - Stocktwits
Why is ENVB stock rising today? - MSN
Top Biotech Stocks To ConsiderDecember 10th - MarketBeat
Enveric Biosciences announces issuance of U.S. patent - Yahoo Finance
ENVERIC BIOSCIENCES, INC. (ENVB) - MSN
Enveric Biosciences Announces Patent Issuance - BioSpace
Enveric Biosciences receives new patent for neuropsychiatric treatments By Investing.com - Investing.com Canada
Enveric Biosciences Inc Stock (ENVB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.23%
1.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):